Clinical trial
Assessment of the Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome - a Randomized Double-blind Placebo-controlled Study
NCT05064930 is registered in ClinicalTrials.gov with Nordic Biotic Sp. z o.o. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome - a Randomized Double-blind Placebo-controlled Study
- Lead sponsor
- Nordic Biotic Sp. z o.o.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 1, 2021
- Completion date
- July 31, 2022
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.